APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma. A ...
MADRID — Should patients with resectable non–small cell lung cancer (NSCLC) receive adjuvant therapy, neoadjuvant therapy, or both experts asked during a special session at the European Society for ...
A new real-world observational study has found that adding adjuvant immunotherapy after surgery does not significantly improve survival outcomes in patients with resectable non-small cell lung cancer ...
Comprehensive in-vivo tool for rheumatoid-arthritis mechanistic research and anti-inflammatory drug screening HUSTON, ...
Three-month adjuvant capecitabine and oxaliplatin treatment can be considered an option for some patients with high-risk stage II colon cancer. More recently, the practice of adjuvant chemotherapy ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Dr Meyerhardt is ...
Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for ...
Cemiplimab significantly improves DFS in patients with high-risk CSCC post-surgery, reducing recurrence or death risk by 68% compared with placebo. The C-POST trial marks the first immunotherapy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results